Materias dentro de su búsqueda.
Mostrando 241 - 260 Resultados de 312 Para Buscar '"Gavi"', tiempo de consulta: 0.21s Limitar resultados
  1. 241
    “…Most of this evidence examines transitions related to human immunodeficiency virus/Acquired Immune Deficiency Syndrome (AIDS; n = 45, 50%) and immunization programmes (n = 14, 16%), with a focus on donors such as the Global Fund to Fight AIDS, Tuberculosis and Malaria (n = 26, 29%) and Gavi, the Vaccine Alliance (n = 15, 17%). Donor transitions are influenced by the actions of both donors and country governments, with impacts on every component of the health system. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The impacts of donor transitions on health systems in middle-income countries: a scoping review
  2. 242
    “…Although not a challenge now due to Gavi support, vaccine costs are a major threat to sustainability in the long run. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    An Evaluation of the Cost of Human Papilloma Virus (HPV) Vaccine Delivery In Zambia
  3. 243
    “…Vaccination strategies combined with five delivery approaches in different age groups compared to no vaccination were considered from the societal perspective, using the Gavi price of 1.5 USD per dose. The vaccination program was considered to be cost-effective if the incremental cost-effectiveness ratio was less than a threshold of 1 GDP per capita for Lao PDR, equivalent to USD 2,535 in 2020. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Cost-effectiveness analysis of typhoid vaccination in Lao PDR
  4. 244
    “…BACKGROUND: Pneumococcal conjugate vaccine strategies in GAVI-eligible countries are focusing on infant immunization but this strategy may not be optimal in all settings. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    African meningitis belt pneumococcal disease epidemiology indicates a need for an effective serotype 1 containing vaccine, including for older children and adults
  5. 245
    por Kim, Sun-Young, Lee, Gene, Goldie, Sue J
    Publicado 2010
    “…BACKGROUND: Gambia is the second GAVI support-eligible country to introduce the 7-valent pneumococcal conjugate vaccine (PCV7), but a country-specific cost-effectiveness analysis of the vaccine is not available. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Economic evaluation of pneumococcal conjugate vaccination in The Gambia
  6. 246
    “…We sought to determine monovalent rotavirus vaccine cost-effectiveness in Malawi, one of Africa's poorest countries and the first Gavi-eligible country to report disease reduction following introduction in 2012. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Cost-Effectiveness of Monovalent Rotavirus Vaccination of Infants in Malawi: A Postintroduction Analysis Using Individual Patient–Level Costing Data
  7. 247
    “…Nicaragua was the first country eligible for funding from the GAVI Alliance to introduce the 13-valent pneumococcal conjugate vaccine (PCV13), provided to infants at 2, 4, and 6 months of age. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Changes in Pneumonia Incidence and Infant Mortality 5 Years Following Introduction of the 13-valent Pneumococcal Conjugate Vaccine in a “3+0” Schedule in Nicaragua
  8. 248
    “…METHODS: An electronic search of six online databases was performed, in addition to websites of the WHO, Global Alliance for Vaccines and Immunization (GAVI), Oxfam International, Save the Children, Community Health Workers Central (CHW Central), UNAIDS and UNICEF. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Pre- and in-service training of health care workers on immunization data management in LMICs: a scoping review
  9. 249
    “…The WHO African region is expected to gain the greatest health benefits and should be prioritised for HPV vaccination. FUNDING: Gavi, the Vaccine Alliance; Bill & Melinda Gates Foundation.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Effects of updated demography, disability weights, and cervical cancer burden on estimates of human papillomavirus vaccination impact at the global, regional, and national levels: a PRIME modelling study
  10. 250
    “…Ethiopia launched the human papilloma vaccination for the first time, with the support of the Global Alliance for Vaccine and Immunization (GAVI) in 2018. Therefore, the aim of this study was to assess the acceptability of the human papillomavirus vaccine and associated factors among parents of daughters in Gondar town, Northwest Ethiopia. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Acceptance of Human Papillomavirus Vaccination and Associated Factors Among Parents of Daughters in Gondar Town, Northwest Ethiopia
  11. 251
    “…The CE of maternal vaccination was $US1766–5857 PPP 2018/disability-adjusted life-years (DALYs) for Global Alliance for Vaccines and Immunisation (Gavi)-eligible countries. For England, the maximum cost-effective price of maternal vaccination was estimated at $US81.5 PPP 2018. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Assessment of the Effects of Active Immunisation against Respiratory Syncytial Virus (RSV) using Decision-Analytic Models: A Systematic Review with a Focus on Vaccination Strategies, Modelling Methods and Input Data
  12. 252
    “…To achieve this aim, with the financial support of GAVI, the Vaccine Alliance, in 2016, the Government of Pakistan, UNICEF and the Alliance for Health Policy and Systems Research (AHPSR) launched an Embedded IR for Immunisation Initiative (the Initiative) to explore health systems and implementation bottlenecks, and potential strategies to tackle such bottlenecks in the Expanded Programme on Immunisation (EPI) in Pakistan. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    An embedded implementation research initiative to tackle service delivery bottlenecks in the expanded programme on immunisation in Pakistan: Overview and reflections
  13. 253
    “…Building on all published results, our predictions support introducing and expanding HPV vaccination, especially in countries that are eligible for subsidized vaccines from GAVI, the Vaccine Alliance, and Pan American Health Organization.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Cost-effectiveness of HPV vaccination in 195 countries: A meta-regression analysis
  14. 254
    “…INTERPRETATION: To reach regional elimination goals, it will be necessary to innovate vaccination strategies and technologies that increase spatial equity of routine vaccination, in addition to investing in existing surveillance and outbreak response programmes. FUNDING: WHO, Gavi, the Vaccine Alliance, US Centers for Disease Control and Prevention, and the Bill & Melinda Gates Foundation.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Feasibility of measles and rubella vaccination programmes for disease elimination: a modelling study
  15. 255
    “…INTERPRETATION: This study serves as a baseline for continued inequality monitoring and could help to inform targeted actions for the equitable uptake of vaccines. FUNDING: Gavi, the Vaccine Alliance.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Global state of education-related inequality in COVID-19 vaccine coverage, structural barriers, vaccine hesitancy, and vaccine refusal: findings from the Global COVID-19 Trends and Impact Survey
  16. 256
    “…The interplay between MCV1, MCV2, and SIAs should be considered when planning future measles vaccination strategies. FUNDING: Gavi, the Vaccine Alliance and the Bill & Melinda Gates Foundation.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Health effects of routine measles vaccination and supplementary immunisation activities in 14 high-burden countries: a Dynamic Measles Immunization Calculation Engine (DynaMICE) modelling study
  17. 257
    por Gunasekaran, Pradeep Kumar, Shanmugasundaram, Devika, Santhanam, Sridhar, Verma, Sanjay, Singh, Kuldeep, Dwibedi, Bhagirathi, Awasthi, Shally, Singh, Himabindu, Sangappa, Mahantesh, Mondal, Nivedita, Sreenivasan, Priya, Saradakutty, Geetha, Malik, Shikha, Jain, Manish, Viswanathan, Rajlakshmi, Sapkal, Gajanan, Tripathi, Shalini, Patel, Bhupeshwari, Jain, Mahendra Kumar, Naganur, Sanjeev Hanumantacharya, Baranwal, Arun, Rohit, Manoj K, Deora, Surender, Sharma, Akhil, Anantharaj, Avinash, Pillai, Lakshmi Sadasivan, Kumar, Amber, Ramasamy, Sabarinathan, Rajendran, Padma Priya, Singh, Mini P., Ratho, Radha Kanta, Nag, Vijaylakshmi, Gadepalli, Ravishekhar, Mishra, Baijayantimala, Som, Tapas Kumar, Jain, Amita, Devara, Sudha Madhuri, Vannavada, Sudha Rani, Munivenkatappa, Ashok, Abraham, Asha Mary, Dhodapkar, Rahul, Ali, Syed, Biswas, Debasis, Pratkeye, Deepashri, Bavdekar, Ashish, Prakash, Jayant, Ray, Jaydeb, Murhekar, Manoj
    Publicado 2023
    “…FUNDING: 10.13039/501100007334Ministry of Health and Family Welfare, Govt of India, through Gavi, the Vaccine Alliance.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Profile of cardiac lesions among laboratory confirmed congenital rubella syndrome (CRS) infants: a nationwide sentinel surveillance, India, 2016–22
  18. 258
    “…This method has been used by the Global Alliance for Vaccines and Immunization (GAVI Alliance) to estimate the potential impact of future vaccination campaigns. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Yellow Fever in Africa: Estimating the Burden of Disease and Impact of Mass Vaccination from Outbreak and Serological Data
  19. 259
    “…BACKGROUND: Since 2000, the Global Alliance for Vaccines and Immunization (GAVI) and WHO have supported the introduction of the Pneumococcal Conjugate Vaccine (PCV) in the immunization programs of developing countries. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Identifying an appropriate PCV for use in Senegal, recent insights concerning Streptococcus pneumoniaeNP carriage and IPD in Dakar
  20. 260
    “…Findings demonstrate the substantial impact of vaccine price in middle-income countries that are not eligible for assistance from Gavi, the Vaccine Alliance. Replacing routine cytology with HPV-based screening may reduce total costs. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Resources Required for Cervical Cancer Prevention in Low- and Middle-Income Countries
Herramientas de búsqueda: RSS